Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Capital Hilton

28 oct 2024 8:30 a.m. - 30 oct 2024 12:40 p.m.

1001 16th Street NW, Washington, DC 20036-5794

DIA/FDA Oligonucleotide-Based Therapeutics Conference

Session 11: Grand Q&A Panel

Speaker(s)

Ramesh  Raghavachari, PhD

Session 11: Grand Q and A Panel

Ramesh Raghavachari, PhD

FDA, United States

Supervisor, Unit 3/DPQA IV/OPQA I/OPQ/CDER

Barry  Ticho, MD, PhD

Speaker

Barry Ticho, MD, PhD

Stoke Therapeutics, United States

Chief Medical Officer

Hobart  Rogers, PharmD, PhD

Speakers

Hobart Rogers, PharmD, PhD

FDA, United States

Pharmacologist

Firoz  Antia, PhD

Speaker

Firoz Antia, PhD

Denali Therapeutics, United States

Vice President, Oligonucleotide and Small Molecule CMC

Andreas  Kuhn, PhD

Speaker

Andreas Kuhn, PhD

Biontech SE, Germany

Senior Vice President RNA Biochemistry & CMC Development

Jeffrey  Foy, PhD

Speaker

Jeffrey Foy, PhD

PepGen Inc., United States

Senior VP, Toxicology

Ronald  Wange, PhD

Speaker

Ronald Wange, PhD

FDA, United States

Associate Director for Pharm/Tox OND

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.